MedReps

JANUARY 30, 2023

If you know how to prepare and get ahead of your competition, reaching your goals will be that much easier. Medical Sales Trends to Watch Out For in 2023 If you want to know what the future holds and create some forward-thinking sales goals, then check out these medical sales trends to watch out for in 2023.

Medical sales 74

Medical sales Medical Sales Sales goal 74

Healthcare Success

NOVEMBER 7, 2022

They’re researching key trends that will attract new high-intent audiences, increase engagement, drive revenue, and reinforce patient loyalty in 2023. In this article, you’ll learn: 4 Advertising Planning Strategies for 2023 6 Marketing Strategies That Outpace Market Disruption. 4 Advertising Planning Strategies for 2023.

Marketing 52

Marketing Media Healthcare Healthcare 52

World of DTC Marketing

MARCH 17, 2021

Pharma has gone to court again and again to delay generic competition of biologic drugs. One company AbbVie has used the courts to stop competition of its top drug Humira. sales until at least 2023 because 257 patent filings stand in the way. In fact, Richard Gonzalez, C.E.O.

Pharma 186

Pharma Competition Prescription Sales 186

pharmaphorum

DECEMBER 15, 2022

The Association of the British Pharmaceutical Industry (ABPI) said today that in 2023 manufacturers of branded medicines will have to return almost £3.3 “The industry now regards the current approach, due to end in 2023, as broken.” billion (around $4 billion) in revenue to the government – 26.5% VPAS tax on top. .

Pharma 72

Pharma Government Manufacturing Medicine 72

PM360

NOVEMBER 13, 2023

When it comes to platforms used by HCPs to better understand prescription drug pricing information, GoodRx is second only to a provider’s electronic health record (EHR). PRECISIONxtract 2023 Annual HCP Survey. Edelman, “2023 Trust Barometer Report,” accessed October 26, 2023. As of Q1 2023, based on GoodRx internal data.

Media 52

Media Prescription Healthcare Provider Patients 52

Pharmaceutical Technology

JANUARY 30, 2023

on National Health Service (NHS) sales of branded medicines in 2023, almost double that of the previous year, has sent shock waves through the pharma industry. Full details of the government’s 2023 VPAS payment calculation may be accessed on the UK Department of Health and Social Care (DHSC) page here. billion ($4.1

Government 97

Government Pharma Sales Medicine 97

PM360

SEPTEMBER 21, 2023

As many in the industry now know, the Inflation Reduction Act (IRA) is the most significant reform of Medicare prescription drug coverage since the creation of Part D and has wide-ranging implications for the healthcare industry. They do not have biosimilar or generic competition available in the market.

Manufacturing 111

Manufacturing Marketing Competition Physicians 111

Clarivate

AUGUST 7, 2024

Express Scripts pioneered a transparent model with ClearCareRx in April, 2023. Express Scripts added ClearNetwork in late 2023, while CVS Caremark introduced CostVantage and TrueCost in early 2024, mirroring the strategies of ESI and OptumRx. The pricing estimates are not guaranteed, leading to potential unexpected expenses.

Retail 59

Retail Marketing Competition Biopharma 59

European Pharmaceutical Review

NOVEMBER 8, 2022

In the current US Congressional session, Congress has focused heavily on legislation directed at reducing prescription drug prices. 1435 (“Affordable Prescriptions for Patients Act of 2021”), [link] gov/bill/117th-congress/senate-bill/1435/text; H.R. Actavis, 570 U.S. 136 (2013), [link] opinions/12pdf/12-416_m5n0.pdf.

Food and Drug Administration 52

Food and Drug Administration Pharma Manufacturing Prescription 52

PM360

APRIL 7, 2023

This program, powered by GoodRx, bills itself as: “Free prescriptions, plus hundreds of prescriptions for $6 or less with membership.” These prescriptions fall into the same boat as the other two offerings—generic medications for some of the most common conditions.

Marketing 52

Marketing Prescription Insurance Retail 52

Clarivate

JULY 5, 2023

The Biosimilars Forum has hailed 2022 as a watershed year that could create a more competitive U.S. biologics market and reduce prescription drug costs. When AMJETIVA finally launched at the end of January 2023, its unusual, tiered pricing strategy made headlines. from 91% in 2023 to 36% by 2031.

Marketing 97

Marketing Physicians Manufacturing Competition 97

European Pharmaceutical Review

JULY 4, 2024

1 For use as prescription drugs, a botanical product must be approved by the FDA: to date, only two have gained this approval. The MA pathway is applicable for herbal medicines designed to treat more serious health conditions and require a medical prescription or the supervision of a medical practitioner. 2012/1916).

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103

Clarivate

APRIL 18, 2024

Amazon’s big splash happened in February 2023 when it purchased the national primary-care practice One Medical for $3.9 RxPass offers more than 50 select prescriptions at no additional cost for $5 per month. billion, following an earlier failed healthcare venture with Berkshire Hathaway and JPMorgan Chase.

Retail 52

Retail Healthcare Healthcare Physicians 52

Clarivate

OCTOBER 25, 2023

While more expensive than type 2 diabetes drugs, blood thinners follow a similar pattern of high prescription volumes. Humira, the long-running blockbuster autoimmune drug, was not eligible for negotiations since it will have nine biosimilars on the market by the end of 2023. With 27.5%

Prescription 52

Prescription Physicians Manufacturing Healthcare 52

Pharmaceutical Technology

DECEMBER 15, 2022

They requested recognition that the prescription medicines sector is critical in the EU and that national emergency plans for gas/oil supplies should apply, reducing the complexity and cost of regulatory compliance and reform of medicines procurement and pricing models. This has significantly increased the cost of energy in Europe.

Transportation 98

Transportation Medicine Manufacturing Pharma 98

PM360

DECEMBER 14, 2022

that didn’t stop us from asking 10 industry experts to take their best shot at anticipating what to expect in 2023 and beyond. So, in order to help best prepare you for what might come, we asked these 10 individuals to peer into their crystal balls and let us know: What will be the biggest trend(s) marketers will be talking about in 2023?

Marketing 91

Marketing Patients Healthcare Healthcare 91

PM360

MAY 15, 2023

Because nearly all prescriptions are now written electronically. First, “Effect of Nudges to Clinicians, Patients, or Both to Increase Statin Prescribing: A Cluster Randomized Clinical Trial,” by Srinath Adusumalli and colleagues in JAMA Cardiology , 2023. And to do that in today’s digital age, you’ve got to think “EHR.”

Marketing 52

Marketing Electronics Doctors Physicians 52

PM360

JUNE 16, 2023

population will result in substantial pockets of differences in prescription drug sales potential due to age, income, ethnicity, and the ability to pay within smaller and smaller geographies. The other is a “sales force access” competitive market, meaning limited rep access to HCPs. Rapidly changing characteristics of the U.S.

Marketing 59

Marketing Sales Healthcare Healthcare 59

Nixon Gwilt Law

JANUARY 16, 2024

The Perennial Trend: Weight Loss You may not realize it, but you probably know someone taking a GLP-1 prescription (glucagon-like peptide-1 receptor agonists like Ozempic and semaglutide) to shed pounds. Rebecca says, “ New and existing companies will offer GLP-1 prescriptions for weight loss.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Nixon Gwilt Law

JANUARY 16, 2024

The Perennial Trend: Weight Loss You may not realize it, but you probably know someone taking a GLP-1 prescription (glucagon-like peptide-1 receptor agonists like Ozempic and semaglutide) to shed pounds. Rebecca says, “ New and existing companies will offer GLP-1 prescriptions for weight loss.

Healthcare 52

Healthcare Healthcare Management Insurance 52

Clarify Health

MARCH 1, 2023

There was a significant decrease in pills per prescription both for peer comparison feedback and for the combination of peer comparison and individual audit feedback. pills per prescription than non-discordant clinicians. 2023), A Site-of-Service Intervention to Change Physician Behavior and Generate Net Savings.

Physicians 52

Physicians Prescription Medicine Healthcare 52

Rep-Lite

MARCH 21, 2024

Importance of Understanding Medical Sales Reps Earnings Understanding the earnings landscape of medical sales jobs is crucial to career planning, negotiation, and employer competitiveness. In 2023, sales amounted to about 863 million dollars. Take for instance Libtayo which was the top-selling product for Regeneron Pharmaceuticals.

Medical sales 52

Medical sales Medical sales reps Sales Medical 52

Rep-Lite

JUNE 28, 2023

According to recent statistics, the global medical technology market is projected to reach a staggering US$570.70bn in 2023. Generally, entry-level positions offer competitive base salaries with the opportunity to earn significant bonuses or commissions based on performance.

Medical sales 52

Medical sales Sales Medical Medical sales reps 52

PM360

NOVEMBER 21, 2022

What will be the biggest changes in the point of care marketing space in 2023 and beyond? As more and more brands try to compete for these digital spaces in 2023 and beyond, they will always face the challenge of staying relevant in the moment and establishing the value of a continued conversation. Matthew Stumm. Akeel Williams.

Marketing 52

Marketing Physicians Patients Doctors 52

PM360

SEPTEMBER 28, 2022

In April 2022, we released an article describing proposed policies from the federal government that could impact prescription drug pricing. The facts: Medicare Part D bids for plan year 2023 were submitted before the IRA was signed. On August 16, 2022, President Biden signed the Inflation Reduction Act (IRA) into law.

Government 97

Government Manufacturing Prescription Competition 97

Pharmaceutical Technology

DECEMBER 4, 2022

Others are made by big pharma giants like Boehringer Ingelheim , Novartis , or Pfizer , which has raised the expectations for a competitive market. . Indeed, Amgen’s biosimilar was approved in September 2016, but the company was not able to launch it until January 2023 in the US. Temporary first-to-market advantage.

Marketing 104

Marketing Physicians Competition Patients 104

Pharmaceutical Technology

MAY 26, 2023

The FDA has flagged this issue as pharmacies selling prescription drugs illegally have proliferated over the years. The US Food and Drug Administration (FDA commissioner Dr. Robert Califf says, “The illegal sale of prescription drug stimulants online puts Americans at risk and contributes to potential abuse, misuse, and overdose.”

Food and Drug Administration 52

Food and Drug Administration Prescription FDA Medical 52

Pharmaceutical Technology

JANUARY 6, 2023

The alleged actions violated the Hatch-Waxman Act, formally known as the “Drug Price Competition and Patent Term Restoration Act of 1984,” which allows generic manufacturers to market their generic versions of previously approved generic medications. These actions allegedly led to the extension of Novartis’ patents.

Pharmaceutical 97

Pharmaceutical Doctors Healthcare Provider Prescription 97

Pharmaceutical Technology

APRIL 21, 2023

On March 29, 2023, the US Food and Drug Administration (FDA) granted approval that made Narcan the opioid treatment drug to be sold without a prescription. The overdose US death rate that has seen a 250% increase from 1999 to 2019. 2021 was a year of continued innovation and change in the Biopharmaceutical industry.

Food and Drug Administration 52

Food and Drug Administration Retail Prescription Management 52

Pharmaceutical Technology

MAY 4, 2023

Furthermore, in April 2023, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) gave a positive opinion in support of the vaccine’s approval. Pfizer’s RSV vaccine will soon also face a US regulatory decision with an upcoming Prescription Drug User Fee Act (PDUFA) date later in May.

FDA 64

FDA Safety Medicine Prescription 64

Pharmaceutical Technology

MAY 9, 2023

The spray can be used for diagnostic procedures and conditions where short-term pupil dilation is necessary, such as cataract surgery or corrective prescriptions. The company will provide further updates on Mydcombi and its ongoing development programs and partnerships during its scheduled Q1 2023 update conference call on May 11.

FDA 52

FDA Prescription Prospecting Medical 52

Pharmaceutical Technology

MAY 15, 2023

The FDA will assess the drug’s approval before its Prescription Drug User Fee Act (PDUFA) date on 29 May 2023. As the COVID-19 pandemic continues to take its toll on businesses worldwide, it’s time to look for new ways to create value, prepare for the future, and remain competitive in the ever-changing landscape.

FDA 52

FDA Food and Drug Administration Prescription Prospecting 52

Pharmaceutical Technology

MAY 1, 2023

After a US Food and Drug Administration (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) Advisory Committee (AdCom) meeting in March 2023 voted unanimously in support of GSK’s respiratory syncytial virus vaccine, the odds for an approval have increased.

Food and Drug Administration 52

Food and Drug Administration Pharmaceutical Medicine Marketing 52

Clarivate

OCTOBER 17, 2024

Since the government first created a Part D benefit with the Medicare Modernization Act of 2003 (MMA) , Democrats have agitated for greater governmental input into the cost of prescription drugs for Medicare beneficiaries. Such a change would sharply increase the number of people covered under this program.

Healthcare 52

Healthcare Healthcare Government Insurance 52